15 results
S-8
ANIX
Anixa Biosciences, Inc.
16 Jan 24
Registration of securities for employees
4:43pm
with these regulations or to recruit a sufficient number of patients may require us to repeat clinical trials, which would delay the regulatory approval process
S-8
ANIX
Anixa Biosciences, Inc.
4 Jan 22
Registration of securities for employees
4:12pm
number of test patients. Our failure or any failure by these third parties to comply with these regulations or to recruit a sufficient number of patients … to recruit patients to participate in our clinical trials; and any closures of our and our business partners’ offices and facilities.
While the Company
424B5
ANIX
Anixa Biosciences, Inc.
24 Mar 21
Prospectus supplement for primary offering
4:15pm
number of test patients. Our failure or any failure by these third parties to comply with these regulations or to recruit a sufficient number of patients
424B5
txil001tu31yqi wfyd
22 Mar 21
Prospectus supplement for primary offering
5:16pm
S-8
wabcco2hnyqd9 kv
7 Jan 21
Registration of securities for employees
4:18pm
- Prev
- 1
- Next